Crucially, although our data have demonstrated that mutations at residue K28 attenuated the efficiency of ZIKV to antagonize STAT2, it was only evaluated in an infection model comprising A549 cells with competent and defective IFN-I-signaling. Here, STAT2 is linked to infection.